CN1127978C - Hyperosteogeny treating medicine - Google Patents
Hyperosteogeny treating medicine Download PDFInfo
- Publication number
- CN1127978C CN1127978C CN99114886A CN99114886A CN1127978C CN 1127978 C CN1127978 C CN 1127978C CN 99114886 A CN99114886 A CN 99114886A CN 99114886 A CN99114886 A CN 99114886A CN 1127978 C CN1127978 C CN 1127978C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- medicine according
- components
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a medicine for treating hyperosteogeny, which is composed of main medicines and auxiliary medicines, wherein desertliving cistanche, degelatined deer-horn, pyrola herb, long-noded pit viper, pangolin scale, kudzuvine root, etc. are used as the main medicines; matrimony vine, laminaria, safflower, common monkshood mother root, malt, corydalis tuber, etc. are used as auxiliary medicines. The medicine has the functions of nourishing the kidney, softening hard masses, strengthening the spleen and stomach, eliminating dampness, killing pains, rapidly infiltrating, etc. The medicine has the advantages of short course of treatment, enhancement of calcium ion metabolism, effective prevention of osteophyma formation, no toxic side effect, convenient and taking and portability. In addition, the effective rate of the medicine can reach 98% and the curative rate of the medicine can reach more than 90%. Thereby, the medicine is an effective medicine for treating hyperosteogeny at present.
Description
The present invention relates to a kind of pharmaceutical composition for the treatment of hyperosteogeny, especially relating to a kind of is the hyperosteogeny medicine that raw material is made with the vegetable Chinese herbal medicine.
Hyperosteogeny belongs to degenerative osteoarthritis, and it is natural wastage and catabiosis in the Human Physiology change procedure, thereby is a kind of common frequently-occurring disease in middle-aged and elderly people.From the doctor trained in Western medicine angle think this sick main diseases because of being because the calcareous forfeiture of bone is the calcium ion metabolic function goes down and cause bone network cell to reduce causing.The traditional Chinese medical science thinks that then this disease is because due to the caused by liver and kidney deficiency, promptly deficiency of the kidney then bone decline, deficiency of the liver then Jinsuo, insufficiency of the spleen then flesh flaccidity.
On the clinical treatment of hyperosteogeny, the Therapeutic Principle of doctor trained in Western medicine is antiinflammatory, analgesia, as uses some antibiotic medicine or analgesic, and commonly used have dexamethasone, an ibuprofen etc.The employing androgen that also has, vitamin, sour calcium, long-acting calcitonins etc. are treated, but curative effect only is to alleviate clinical symptoms.Though what have imposes on operation, can not dig up the roots.And the traditional Chinese medical science mainly is with invigorating the liver and kidney, wind-damp dispelling, and reducing swelling and alleviating pain, relaxing muscles and tendons to promote blood circulation are main, are aided with existing Chinese herb medicine and treat, and as HUOLUO WAN, ZHUANGGU WAN or the like, do not control root but also just control table, therefore, still can not fundamentally solve patient's misery.
The object of the present invention is to provide a kind of have the kidney invigorating, softening the hard mass, spleen invigorating, active, analgesic pure natural plant type medicine for treating osteoproliferation.
Solution of the present invention is according to understanding and the Therapeutic Principle of Chinese medicine to bone matrix hyperplasia, from China's medicine treasure-house, filter out invigorating kidney, promoting blood circulation, softening the hard mass damp eliminating, remove the channels cold-phlegm, strengthening the spleen and stomach promotes the production of body fluid, relaxing muscles and tendons and activating QI and blood in the collateral, remove the natural edible plant amedica of wind damp eliminating, easing pain and diminishing inflammation, rapid osmotic, through scientific and rational compatibility, make that its performance negative and positive develop simultaneously, internal and external application, cold and heat are gone forward side by side, disappeared mends synchronous effect.
Medicine of the present invention is the medicament of being made by the raw material of following weight portion:
Herba Cistanches 5-20 Cornu Cervi Degelatinatum 5-30 Herba Pyrolae 5-15
Agkistrodon 1-15 Squama Manis 5-15 Radix Puerariae 5-15
Fructus Lycii 10-20 Thallus Laminariae (Thallus Eckloniae) 3-9 Flos Carthami 5-10
Radix Aconiti 3-8 Fructus Hordei Germinatus 5-10 Rhizoma Corydalis 5-8.
Medicine of the present invention is the medicament of being made by the raw material of following weight portion:
Herba Cistanches 10-15 Cornu Cervi Degelatinatum 10-20 deer rank leather 8-10
Agkistrodon 5-10 Squama Manis 5-10 Radix Puerariae 5-10
Fructus Lycii 15-20 Thallus Laminariae (Thallus Eckloniae) 5-6 Flos Carthami 6-9
Radix Aconiti 5-7 Fructus Hordei Germinatus 6-8 Rhizoma Corydalis 6-7.
Medicine of the present invention is the medicament of being made by the raw material of following weight portion:
Herba Cistanches 5 Cornu Cervi Degelatinatums 5 Herba Pyrolaes 6
Agkistrodon 5 Squama Maniss 8 Radix Puerariaes 10
Fructus Lycii 10 Thallus Laminariae (Thallus Eckloniae)s 6 Flos Carthamis 9
Radix Aconiti 7 Fructus Hordei Germinatus 8 Rhizoma Corydalis 8.
Fructus Lycii in the said components can replace with Radix Rehmanniae Preparata or the Radix Polygoni Multiflori, matches with combination and Herba Cistanches a kind of or between them in them, effect such as promptly play warming and recuperating the kidney-YANG, hemopoietic, enrich blood, invigorate blood circulation, with the invigorating kidney, promoting blood circulation is earlier, kidney storing essence, the smart marrow of giving birth to, marrow nourishing bone strengthens hemopoietic function.
Flos Carthami in the said components can replace with Caulis Spatholobi, with the diversion of can building canals of a kind of in them or the combination between them and Herba Pyrolae compatibility, promptly dredges the muscle arteries and veins, makes the QI and blood smoothness without hindrance, reaches not bitterly curative effect of general rule.
Radix Aconiti in the said components can replace with Radix Aconiti Kusnezoffii, with a kind of in them or combination and Agkistrodon compatibility between them, cold coagulation is melted, and drives away network apoplexy, cold, wet three heresies.
Fructus Hordei Germinatus in the said components can replace with Fructus Setariae Germinatus, matches with combination and Radix Puerariaes a kind of or between them in them, and the strengthening the spleen and stomach that can promote the production of body fluid promotes the absorption of calcium, separates all poison, and can remove muscle spasm pain.
Thallus Laminariae (Thallus Eckloniae) in the said components can replace with Sargassum, with a kind of in them or combination and Cornu Cervi Degelatinatum compatibility between them, has other medicines softening the hard mass function can't be obtained, makes outgrowth hyperosteogeny softening and eliminate gradually.
Rhizoma Corydalis can replace with Pericarpium Papaveris, can strengthen analgesic effect with the combinations a kind of or between them in them.Also can add Rhizoma Arisaematis or other medicines in the compatibility in addition, so that get rid of phlegm-damp.
Bone matrix hyperplasia is a kind of disease of invading the joint, and there is certain process at the absorption of medicine and sick Du's of arrival position, therefore, allocates Squama Manis into and can make medicine arrive lesions position as early as possible, thereby improve curative effect.
The invention has the advantages that its collection invigorating kidney, promoting blood circulation, softening the hard mass damp eliminating, remove the channels cold-phlegm, strengthening the spleen and stomach promotes the production of body fluid, relaxing muscles and tendons and activating QI and blood in the collateral, remove wind damp eliminating, easing pain and diminishing inflammation, rapid osmotic eight big functions and be dissolved in one mutually, and strengthening the spleen and stomach promotes the production of body fluid, hard masses softening and resolving, remove the meridians cold-phlegm, rapid osmotic is comparatively significant, therefore, the course of treatment can be shortened, strengthen the calcium ion metabolic function, strengthen the active and regeneration of bone network cell, reduce the forfeiture of bone calcium, thereby prevent the formation of hyperosteogeny effectively, eliminate the super part that increases, and can not recur.In addition, except that treating hyperosteogeny, Fengshi Guanjie, rheumatoid all there is significant curative effect, by the clinical verification of 900 many cases, effective percentage reaches 98%, and cure rate is more than 90%, do not have any toxicity, side effect, and carry, taking convenience, be the active drug for the treatment of bone matrix hyperplasia at present.
Embodiment 1
According to following proportioning (kilogram), with existing processing method with each medicine pulverize, heating takes medicine juice, filtration, makes paste after concentrating, and is reprocessed into powder after the drying:
Herba Cistanches 5 Cornu Cervi Degelatinatums 5 Herba Pyrolaes 6
Agkistrodon 5 Squama Maniss 8 Radix Puerariaes 10
Fructus Lycii 10 Thallus Laminariae (Thallus Eckloniae)s 6 Flos Carthamis 9
Radix Aconiti 7 Fructus Hordei Germinatus 8 Rhizoma Corydalis 8.
Embodiment 2
According to following proportioning (kilogram), each medicine is processed into powder with existing processing method:
Herba Cistanches 20 Cornu Cervi Degelatinatums 25 Herba Pyrolaes 15
Agkistrodon 15 Squama Maniss 15 Radix Puerariaes 15
Radix Rehmanniae Preparata 10 Sargassums 3 Caulis Spatholobis 7
Fructus Lycii 10 Thallus Laminariae (Thallus Eckloniae)s 3 Flos Carthamis 7
Radix Aconiti 5 Fructus Hordei Germinatus 5 Rhizoma Corydalis 5
Radix Aconiti Kusnezoffii 5 Fructus Setariae Germinatuss 5 Pericarpium Papaveriss 5.
Embodiment 3
According to following proportioning (kilogram), each medicine is processed into powder: Herba Cistanches 10 Cornu Cervi Degelatinatums 15 Herba Pyrolaes 10 Agkistrodons 10 Squama Maniss 10 Radix Puerariaes 15 Radix Rehmanniaes Preparata 5 Sargassums 3 Caulis Spatholobis 7 Fructus Lyciis 10 Thallus Laminariae (Thallus Eckloniae)s 6 Flos Carthamis 8 Radix Aconitis 5 Fructus Hordei Germinatus 5 Rhizoma Corydalis 5 Radix Aconiti Kusnezoffii 5 Fructus Setariae Germinatuss 3 Pericarpium Papaveriss 3 Radixs Polygoni Multiflori 5 with existing processing method.
Claims (9)
1, a kind of hyperosteogeny medicine is characterized in that it is the medicament of being made by the raw material of following weight portion:
Herba Cistanches 5-20 Cornu Cervi Degelatinatum 5-30 Herba Pyrolae 5-15
Agkistrodon 1-15 Squama Manis 5-15 Radix Puerariae 5-15
Fructus Lycii 10-20 Thallus Laminariae (Thallus Eckloniae) 3-9 Flos Carthami 5-10
Radix Aconiti 3-8 Fructus Hordei Germinatus 5-10 Rhizoma Corydalis 5-8.
2, medicine according to claim 1 is characterized in that the components by weight percent of each raw material is:
Herba Cistanches 10-15 Cornu Cervi Degelatinatum 10-20 Herba Pyrolae 8-10
Agkistrodon 5-10 Squama Manis 5-10 Radix Puerariae 5-10
Fructus Lycii 15-20 Thallus Laminariae (Thallus Eckloniae) 5-6 Flos Carthami 6-9
Radix Aconiti 5-7 Fructus Hordei Germinatus 6-8 Rhizoma Corydalis 6-7.
3, medicine according to claim 1 is characterized in that the components by weight percent of each raw material is:
Herba Cistanches 5 Cornu Cervi Degelatinatums 5 Herba Pyrolaes 6
Agkistrodon 5 Squama Maniss 8 Radix Puerariaes 10
Fructus Lycii 10 Thallus Laminariae (Thallus Eckloniae)s 6 Flos Carthamis 9
Radix Aconiti 7 Fructus Hordei Germinatus 8 Rhizoma Corydalis 8.
4, medicine according to claim 1 is characterized in that the structure Qi in the said components replaces with a kind of in the Radix Rehmanniae Preparata or the Radix Polygoni Multiflori or their combination.
5, medicine according to claim 1 is characterized in that the Flos Carthami in the said components replaces with Caulis Spatholobi.
6, medicine according to claim 1 is characterized in that the Radix Aconiti in the said components replaces with Radix Aconiti Kusnezoffii.
7, medicine according to claim 1 is characterized in that the Fructus Hordei Germinatus in the said components replaces with Fructus Setariae Germinatus.
8, medicine according to claim 1 is characterized in that the Thallus Laminariae (Thallus Eckloniae) in the said components replaces with Sargassum.
9, medicine according to claim 1 is characterized in that the Rhizoma Corydalis in the said components replaces with Pericarpium Papaveris.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114886A CN1127978C (en) | 1999-05-21 | 1999-05-21 | Hyperosteogeny treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114886A CN1127978C (en) | 1999-05-21 | 1999-05-21 | Hyperosteogeny treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1274597A CN1274597A (en) | 2000-11-29 |
| CN1127978C true CN1127978C (en) | 2003-11-19 |
Family
ID=5277921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99114886A Expired - Fee Related CN1127978C (en) | 1999-05-21 | 1999-05-21 | Hyperosteogeny treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1127978C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100574797C (en) * | 2006-06-23 | 2009-12-30 | 山东华鲁制药有限公司 | A kind of plaster for the treatment of osteopathia |
-
1999
- 1999-05-21 CN CN99114886A patent/CN1127978C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1274597A (en) | 2000-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1084761A (en) | Bone wound medicine (gushangling) | |
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN1079253C (en) | Medicinal oil for dredging channels and collaterals of heart and brain and its preparing process | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1733134A (en) | Chinese traditional medicine for curing bone fracture and process for preparing the same | |
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1059105C (en) | Bi Syndrome curing medicine | |
| CN1657067A (en) | Chinese medicine for treating psoriasis | |
| CN1682811A (en) | Strengthening spine and bone pill ofr treating rigid spondylitis | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN1127978C (en) | Hyperosteogeny treating medicine | |
| CN1768832A (en) | Medicinal wine for treating injuries and falls, waist and leg pain | |
| CN1958046A (en) | Wine for promoting blood circulation and activating the channels | |
| CN106511671A (en) | Medicinal liquor for treating hyperostosis, rheumatism and gout disease | |
| CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
| CN1257745C (en) | Chinese medicinal composition for treating typhoid | |
| CN1101202C (en) | Compound Chinese medicine preparation for treating hyperosteogeny | |
| CN1081047C (en) | Medicinal liquor for treating rheumatism and atrophic arthritis | |
| CN1172701C (en) | Medicine for curing herpes zoster | |
| CN1136864C (en) | Chinese medicine for treating mastoproliferation | |
| CN1733165A (en) | Chinese traditional medicine composition for curing psoriasis, its preparation process and application | |
| CN1122520C (en) | Osteanaphysis capsule for treating femoral head necrosis | |
| CN1241602C (en) | Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases | |
| CN1189186C (en) | Antiphlogistic and analgesic ointment for treating rheumatism and trauma | |
| CN100335082C (en) | Medicine for treating rheumarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |